Crooke Cell Adenoma Presenting With Refractory Hypokalemia and Uncontrolled Hypertension
Abstract
Crooke cell adenomas (CCAs) are a rare subtype of pituitary corticotroph adenomas with a prevalence of less than 1% of pituitary adenomas. CCAs have variable clinical manifestations and can present as functional adenomas secreting adrenocorticotropic hormone (ACTH), resulting in hypercortisolism, as well as silent invasive macroadenomas. CCAs also exhibit a higher risk for recurrence, less biochemical remission, and normalization of pituitary function after tumor resection compared to other secretory corticotroph adenomas. Refractory hypokalemia and hypertension as manifestations of hypercortisolism are more commonly seen in patients with ectopic ACTH syndrome than pituitary-dependent Cushing syndrome. We present a 39-year-old female who presented with refractory hypokalemia, hypertension, lower extremities edema, and newly diagnosed diabetes mellitus. Evaluation revealed an ACTH-dependent hypercortisolemia from a 5- × 3-mm pituitary microadenoma. She underwent transsphenoidal resection of the microadenoma with resolution of symptoms immediately after surgery and up to 20 months of follow-up. The histopathology of the microadenoma revealed more than 50% of corticotrophs demonstrated Crooke hyaline change compatible with Crooke cell adenoma. To our knowledge, only one case of CCA presenting with a microadenoma and similar clinical manifestations has been reported to date. Our case highlights an atypical and infrequent clinical presentation of CCA.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.